At the California ALS Summit held at the Gladstone Institute in San Francisco, Dr. Smith served on a panel that focused on translational medicine and presented an overview of his work on the assessment of speech and swallowing in ALS trials.
top of page
Videos
News
Dr. Smith discussed the assessment of bulbar function in ALS clinical trials at Biogen Pharmaceuticals (Boston), at the ALS Investigator Research Workshop sponsored by ALSA (Philadelphia), and again in Clearwater, Florida at the NEALS annual meeting.
Avanir Pharmaceuticals reported that Nuedexta, a drug discovered at CNS, showed positive clinical results in treating agitation for patients with Alzheimer's disease. For more information, click here.
bottom of page